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Abstract
Background: Sepsis causes extensive morbidity and mortality in children worldwide. Prompt recognition and timely
treatment of sepsis is critical in reducing morbidity and mortality. Genomic approaches are used to discover novel
pathways, therapeutic targets and biomarkers. These may facilitate diagnosis and risk stratification to tailor treatment
strategies.
Objective: To investigate the temporal gene expression during the evolution of sepsis induced multi-organ failure in
response to a single organism, Neisseria meningitidis, in previously healthy children.
Method: RNA was extracted from serial blood samples (6 time points over 48 hours from presentation) from five critically ill
children with meningococcal sepsis. Extracted RNA was hybridized to Affymetrix arrays. The RNA underwent strict quality
control and standardized quantitation. Gene expression results were analyzed using GeneSpring software and Ingenuity
Pathway Analysis.
Result: A marked variability in differential gene expression was observed between time points and between patients
revealing dynamic expression changes during the evolution of sepsis. While there was evidence of time-dependent changes
in expected gene networks including those involving immune responses and inflammatory pathways, temporal variation
was also evident in specific ‘‘biomarkers’’ that have been proposed for diagnostic and risk stratification functions. The extent
and nature of this variability was not readily explained by clinical phenotype.
Conclusion: This is the first study of its kind detailing extensive expression changes in children during the evolution of
sepsis. This highlights a limitation of static or single time point biomarker estimation. Serial estimations or more
comprehensive network approaches may be required to optimize risk stratification in complex, time-critical conditions such
as evolving sepsis.
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Introduction
Sepsis-induced multiple organ failure and the related systemic
inflammatory response syndrome contribute to the vast majority of
deaths during critical illness in adults and children [1]. New
therapies for sepsis-induced multiple organ failure are as far as
ever from delivering survival benefits [2]. Interventional studies
are limited by the heterogeneity of these clinically defined
syndromes of sepsis [3], which also undermine specific anti-
inflammatory therapies [4].
In children, pediatric septic shock continues to be an important
health problem, and despite the development of effective
antibiotics, vaccines and intensive care unit-based support, a
major challenge remains the early recognition of septic shock,
which has been shown to be linked to improved survival [5]. Early
recognition and timely management of meningococcal septicemia
has reduced mortality rate from 20–40% in the late 90s to 5–20%
over the last decade [6]. Clinical predictors of poor outcome have
been recognized for many years and include a low core body
temperature, seizures or shock on initial presentation, neutropenia,
thrombocytopenia, and purpura fulminans [7]. Despite detailed
knowledge of the immunopathology [8] and new developments in
genomics and proteomics, this has yet to be translated into
clinically useful risk prediction.
Several groups have used genomic approaches to probe further
the global gene expression changes during sepsis [9,10]. Biomark-
ers [11] or more realistically patterns on genome-wide expression
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arrays have the potential to provide vital diagnostic and risk
stratification functions [10,12,13]. Gene expression studies using
this approach have been limited to one or two time points
providing snapshots of gene expression during the course of sepsis.
In this study, we investigated the influence of time on the
expression of 28,725 genes in the earliest phases of development of
sepsis-induced multiple organ failure (0, 4, 8, 12, 24 and 48 hours)
in response to a single pathogen (N. meningitis) in a cohort of
children with no pre-existing diseases. We observed an increasing
number of genes that were differentially regulated from admission
(surrogate baseline at 0 hours) with time over the first 48-hours,
showing marked expression instability. This degree of transcript
expression instability was also reflected in biomarker genes that
have been suggested for risk stratification in sepsis [14]. As such,
the changing transcript expression during sepsis reflects the
dynamic nature of the disease evolution, and is therefore a
challenge to microarray analysis for diagnosis and risk stratifica-
tion.
Materials and Methods
Patient recruitment
This study was approved by the Nottingham University ethics
committee (REC reference 05/Q2403/53). Patients presenting to
Nottingham University Hospital Paediatric Intensive Care Unit
(PICU) were recruited, and parents gave full written consent on
behalf of children who took part in the study. The patients
recruited received the standard clinical treatment, including
appropriate antimicrobial therapy for presumed meningococcal
meningitis. Four of the patients subsequently had the diagnosis of
meningococcal Group B bacteria made following polymerase
chain reaction.
Blood sampling
Blood samples were collected from 5 patients on admission to
PICU (designated 0 hours) and subsequently at 4, 8, 12, 24, and
48 hours after their admission. Blood was collected, mixed with
PAXgene Blood RNA reagent and left to incubate at room
temperature before freezing at 280uC.
RNA extraction
Blood and PAXgene Blood RNA reagent were thawed,
incubated at room temperature, and RNA was purified according
to the Qiagen PAXgene Blood RNA manual protocol using the
commercial kit (PAXgene Blood RNA kit, Qiagen). Further
ethanol precipitation steps were necessary to achieve adequate
RNA concentration and purity, which were assessed by spectro-
photometry (A260/A280 ratio, NanoDrop ND-1000 spectropho-
tometer) and capillary electrophoresis (Agilent 2100 Bioanalyzer,
Agilent Inc). The 4-hour sample from Patient 4 was degraded and
was not used for further microarray experiments.
cRNA synthesis and chip hybridization
cRNA synthesis was performed using AmbionH WT Expression
kit, starting with 250 ng total RNA. Following cRNA digestion
with RNase H, labeled cDNA was hybridized onto Human Gene
1.0 ST Arrays (AffymetrixH), and processed according to the
protocol outlined by Affymetrix.
Microarray data analysis
A total of 33,297 probe sets from 29 arrays on the Human Gene
1.0 ST Arrays were analyzed. Complete gene expression data for
each patient are available on the ArrayExpress database (EMBL-
EBI ArrayExpress accession number E-MEXP-3850; http://www.
ebi.ac.uk/arrayexpress/). The raw data files were imported to
GeneSpringGX (version 11.5, Agilent Technologies), normalized
and log-transformed according to the workflow pipeline. Control
probe sets, as well as probes absent on all arrays were excluded
from analysis. Probe sets that differed by $2 fold change between
0-hour samples across the 5 patients were also excluded from
further analysis, resulting in 28,725 probe sets analyzed. For each
patient, probe sets were analyzed for $2-fold change differences
between subsequent time points compared to the respective 0-hour
sample, resulting in 5 pairwise comparisons for each patient (apart
from patient 4 which did not include a 4-hour sample due to RNA
degradation).
Identification of significant pathways
Gene lists generated from GeneSpring were formatted and
uploaded to IngenuityH Pathway Analysis (IPA). This is a web-
Table 1. Patient demographics for longitudinal analysis.
Patient 1 2 3 4 5
Number of samples 5 5 5 5* 5
Age (months) 13 10 22 24 9
Sex Female Female Female Male Male
Duration of PICU admission (days) 9 4 3 6 3
No. of organ(s) in failure 4 4 3 3 3
PELOD score on admission 61 31 31 12 11
PELOD score at 24 hours 52 2 22 22 2
PELOD score at 48 hours 43 2 31 12 1
Median PRISM score 6 6 6 6 6
Infection Negative culture
(Presumed meningococcal
sepsis)
GpB meningococcus GpB meningococcus GpB meningococcus GpB meningococcus
Mortality (at 28 days) Died Alive Alive Alive Alive
PELOD, PEdiatric Logistic Organ Dysfunction Score; PRISM, Pediatric Risk of Mortality Score.
*4-hour sample resulted in degraded RNA, not used for further array experiments.
doi:10.1371/journal.pone.0060501.t001
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Figure 1. Gene expression changes over time. (a) Plot of 28,869 genes with normalized intensity values against time for the 5 patients, from
GeneSpring 11.5 analysis (see Methods). Colors of plots are representative of genes’ change in expression level compared to the corresponding
gene’s expression at 0 hours for patient 1. Blue is for upregulated expression, yellow is for no change in expression, and red is for downregulated
expression compared to patient 1 at time 0. (b) Numbers of genes up- and down-regulated over time for each of the 5 patients, compared to each
patient’s gene expression at 0 hours. The top panel indicates numbers of up-regulated genes, the bottom panel indicates numbers of down-
regulated genes, for patients 1 (N), 2 (&), 3 (D), 4 (x), and 5 (*).
doi:10.1371/journal.pone.0060501.g001
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based analysis tool in which published scientific findings have been
systematically encoded into an ontology and modeled into
molecular networks based on published physical, transcriptional
or enzymatic interactions. Fisher’s exact test was used to calculate
a p-value determining the probability that each biological function
assigned to that dataset is due to chance alone. Networks were
further analyzed for relevance to the particular biological system
and clinical setting.
Results
We studied 5 previously healthy children with a clinical
diagnosis of acute meningococcal septicemia with sepsis-induced
multiple organ failure. Their clinical presentation patterns of
organ failures were similar, as were antimicrobial therapy and
approaches to (but not extent of) organ support (Table 1). Gene
expression in whole blood was determined at time 0 hours (on
admission to pediatric intensive care) and at 4, 8, 12, 24 and
48 hours into their intensive care admission; in total 30 blood
samples were collected.
Twenty-nine microarrays were hybridized, as RNA from the 4-
hour sample from patient 4 had degraded and was not used for
further array experiments. GeneSpring GX software (Agilent
Technologies) was used for initial visualization (Figure 1a) and
subsequent analysis of the microarray data. Figure 1a demon-
strates the complex temporal relationship of disease evolution and
instability of transcript expression that occur with time. In order to
increase the comparability between patients in subsequent
analysis, the signal intensities of 28,869 gene probes of the 0-
hour samples were compared between all 5 patients; 144 gene
probes (0.05% of total number of gene probes) were found to vary
across the patients by $2 fold. Such baseline differences were
interpreted as differential gene expression downstream to events
prior to PICU admission. To aid comparisons between patients,
the differentially regulated genes at baseline were excluded from
subsequent analysis. Further analysis of the remaining 28,725 gene
probes showed differential up- and down- regulation of genes
during the time-course, compared to baseline at admission
(0 hours), for all 5 patients, with the general trend of increasing
numbers of up- and down-regulated genes with time, seen in
varying degrees (Figure 1b).
To determine differential gene expression at specific time points,
genes were grouped based on differential regulation compared to
baseline at admission ($2 fold change in gene expression
compared to gene expression levels at 0 hours) at the 5
subsequently sampled time points (4, 8, 12, 24, 48 hours). Genes
were found to be differentially up- or down-regulated at all time
points throughout the time-course compared to baseline, or were
up- or down-regulated only at distinct time points, with others
overlapping in expression at different time points (Figure 2). The
complexity in gene regulation is clearly demonstrated in this
clinical setting; gene expression changes continue to occur in
patients with evolving meningococcal sepsis beyond 24 and
48 hours.
Networks were generated in IPA using differentially regulated
genes ($2-fold change) between downstream time points com-
pared to baseline at admission to elucidate biological networks
activated during the various time points in the evolution of sepsis.
The mapping of genes to biological networks was accompanied by
a network score, which describes the likelihood that a particular
group of genes are found in the network by chance. The higher the
number of regulated genes within the network, the higher the
Figure 2. Temporal variation in gene expression changes. Numbers of genes that change at different time points as compared to their
baseline gene expression level are shown. Expression levels were analyzed by pairwise comparisons between each of 5 time points (4, 8, 12, 24, and
48 hours) compared to each patient’s corresponding 0 hour gene expression profiles, and expression levels of greater than 2-fold changes were
noted. This was performed for all 5 patients (except in patient 4 where the 4-hour sample had degraded RNA), 24 pairwise comparisons in total.
Numbers in the sections of the Venn diagram correspond to numbers of genes that were up- or down-regulated by $2-fold for at least 1 in the 5
patients; numbers in the outer sections correspond to the numbers of genes uniquely regulated at the corresponding time points, and the number in
the middle corresponds to the number of genes differentially regulated at all time points during the time-course.
doi:10.1371/journal.pone.0060501.g002
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network score, which relates to the negative exponent of the
respective p-value (i.e. network score =2log10(p-value)). Genes
regulated at 4 hours included CXCR5, HLA-DQB1, HLA-DOA, and
were associated with the ‘‘antigen presentation, cellular compro-
mise, infectious disease, respiratory disease’’ network (network
score 46). Genes regulated at 8 hours included TNF, CD86,
IL27RA, MT1F, and were associated with ‘‘cell-to-cell signaling,
inflammatory response, immune cell trafficking’’ networks (net-
work scores 25–33). Genes regulated at 12 hours included HLA-
DRB3, HLA-DPB1, ZNF32, ZBTB16 and were associated with
networks relating to ‘‘cellular growth and proliferation, cellular
assembly and organization, cell-mediated immune responses, cell
death’’ (network scores 28–44). At 24 hours, genes regulated were
associated with similar networks highlighted at 12 hours, with the
addition of networks relating to ‘‘cell cycle, cell morphology,
cellular compromise, DNA replication, recombination and repair,
drug metabolism’’ (network scores 30–58). This group of genes
included CASP1, SAMHD1, ZC3H11A, CDC26. By 48 hours,
differentially regulated genes were associated with similar networks
to those reported at 24 hours, but with the addition of ‘‘protein
synthesis’’ (network scores 33–42). These genes include XAF1,
MX1, OAS2, CD28, BAZ1A. The annotated gene networks
populated by genes found to be uniquely regulated at different
time points in this group of patients are consistent with the
temporal evolution of the biological response to meningococcal
sepsis (Figure 3).
Stratification strategies have been suggested that utilize single
or, more recently, multiple biomarkers as predictors of outcome in
sepsis, taking into account the complexity and heterogeneity of this
clinical syndrome [14]. In this study, the transcript levels of the
panel of 15 suggested biomarkers varied differentially with time:
from ELA2 that did not change during the sampled time-course, to
HSPA1B, CCL4, GZMB and ORM1 that varied across the whole
time-course (Table 2). A selection of the 15 suggested biomarkers
are shown in Figure 4 as transcript expression level over time in
the 5 patients included in this study, and demonstrates the
differential changes in transcript levels across the different
biomarkers.
Figure 3. Ingenuity Pathway Analysis network. Example of a gene network derived from genes uniquely regulated at 48 hours, comprising 3
merged networks consisting of 444 genes (red, increased expression; green, decreased expression) as derived from Ingenuity Pathway Analysis.
Selected regions of the network are highlighted, consisting of genes involved in: (a) Antimicrobial response, Inflammatory response, Cell-To-Cell
Signaling and Interaction (‘‘MX1 genes’’, network score 23); (b) Cell Death, Cell Signaling, DNA Replication, Recombination and Repair (‘‘CASP genes’’,
network score 33); (c) Cellular Development, Hematological System Development and Function, Hematopoiesis (‘‘RB1 genes’’, network score 37).
doi:10.1371/journal.pone.0060501.g003
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Discussion and Conclusion
This study demonstrates the extent of the complexity of
temporal changes in gene expression that occur during the
evolution of sepsis-induced multiple organ failure. The frequent
sampling of individual cases provide a novel insight into the rate of
change of expression with time.
Longitudinal genomic expression profiling analyses in pediatric
septic shock has been reported previously at a lower sampling
frequency (days 1 and 3) [13]. Our study provides a high
resolution temporal analysis of gene expression changes in the
earliest stages of evolving pediatric sepsis. The extent and
persistence of the variability we observed contrasted strikingly
with clinical work and Calvano et al’s volunteer endotoxin model
of systemic inflammation where perturbations in gene expression
returned to baseline by 24 hours [15].
We undertook this study because the majority of deaths from
sepsis in children occur in the first 6 to 24 hours [3,16,17].
Therefore any proposed risk stratification tool must be available
promptly. If not, it will be limited to describing outcomes in the
subset of cases that have survived the initial hazardous period.
Our study has advantages including the high sampling
frequency but also the focus on cases with an acute presentation
of previously healthy children infected with a single pathogen.
These features would be expected to remove several sources of
variability. Despite these common features, the variability in
expression is striking. There was wide variability in expression of
existing candidate biomarkers especially within the first 24 hours.
This variability in transcript level expression displayed by the
panel of 15 candidate genes suggest their utility as a protein
biomarker may be limited. It may be that change in expression
levels of biomarkers are of as much significance as absolute levels.
One of the suggested biomarkers, matrix metalloproteinase 8
(MMP8), has attracted interest as a marker of sepsis severity [18].
Mining previous microarray data, MMP8 transcript expression
was increased in children with septic shock, with higher levels in
non-survivors [18]. This suggests that MMP8 can be used as a
marker of disease severity. Interestingly, in our patients, the
MMP8 expression varied with time across the 5 patients
(Figure 4d). While MMP8 levels were very similar on admission
to intensive care, there was clear divergence by 12 hours, which
persisted at 24 and 48 hours. The degree of organ dysfunction was
markedly greater in patients 1, 3, 4, and this is reflected in the
higher MMP8 expression levels compared to patients 2 and 5.
However, the differences in MMP8 expression levels were not
detected on admission to intensive care; rather, the divergence in
MMP8 transcript expression was only reliably detected at
12 hours into their admission. This supports the need for temporal
consideration in using biomarkers for risk stratification; a single
‘‘snapshot’’ may be less informative than a trend.
The main weakness of this work is our tight focus on 5 children.
Comparisons with more children with sepsis from other organisms
Figure 4. Expression variability of proposed biomarkers for sepsis. The gene expression changes of a selection of proposed biomarkers are
shown, to demonstrate their variability over the time-course. Starting from (a) in clockwise direction: (a) GZMB and (b) CCL4 are up- or down-
regulated compared to 0 hours at all time points (‘‘common’’); (c) IL8 is up- or down-regulated compared to 0 hours at 8, 12, 24, and 48 hours; (d)
MMP8 is up- or down-regulated compared to 0 hours at 12, 24, and 48 hours; (e) CCL3 is up- or down-regulated compared to 0 hours at 24 and
48 hours; (f) SULF2 is up- or down-regulated compared to 0 hours at 48 hours only. Up- and down-regulation is filtered at$2-fold change compared
to 0 hours.
doi:10.1371/journal.pone.0060501.g004
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and with systemic inflammation from non-septic causes are
essential future steps. In addition, correlations between gene
expression changes and protein levels for biomarker assessment
are required. Finally and most challenging would be generating
sufficient power to match specific gene (or gene network)
expression patterns with specific clinical phenotypes. A further
caveat may be the limitation of using time 0 on admission as a
reference baseline. There are wide differences in the pre-hospital
course influencing time of presentation to medical attention and
admission to intensive care. This may have an impact on the
observed biologic variability. A potential solution may be to
standardize to peak expression levels of a selected biomarker gene,
but the problem is that this can only be identified retrospectively.
Other solutions include attempting to take into account lead-time
between initial symptoms and presentation to medical services into
the analysis. The biologic impact of this variability in timings
warrants further exploration.
This study shows that while transcriptional profiling is very
powerful for gaining insight into the interplay between molecular
networks, temporal analyses are required to fully exploit the full
potential of this approach for both understanding disease evolution
and detecting biomarkers in an evolving clinical syndrome such as
sepsis.
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